Sonova Holding (OTCMKTS:SONVY) Short Interest Up 75.8% in July

Sonova Holding (OTCMKTS:SONVY) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totaling 1,508 shares, a growth of 75.8% from the June 30th total of 858 shares. Based on an average trading volume of 36,640 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Sonova Trading Up 0.6%

Shares of Sonova stock opened at $54.78 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75. The business has a 50 day moving average of $50.75 and a 200 day moving average of $49.73. Sonova has a 52 week low of $42.26 and a 52 week high of $61.09.

Wall Street Analysts Forecast Growth

SONVY has been the subject of a number of recent research reports. UBS Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a report on Wednesday, July 22nd. Morgan Stanley upgraded shares of Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. Finally, Citigroup restated a “sell” rating on shares of Sonova in a research report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold”.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.